Výsledky vyhledávání - "Chrisoula Hatzara"

Akademický článek

Conversion and Reversion Rates of Tuberculosis Screening Assays in Patients With Rheumatic Diseases and Negative Baseline Screening Under Long-Term Biologic Treatment

Autor: Konstantinos Thomas, Emilia Hadziyannis, Chrisoula Hatzara, Anastasia Makris, Christina Tsalapaki, Argyro Lazarini, Kalliopi Klavdianou, Katerina Antonatou, Christos Koutsianas, Dimitrios Vassilopoulos

Publikováno v: Pathogens and Immunity, Vol 5, Iss 1, Pp 34-51 (2020)

Background: To determine the conversion and reversion rates of tuberculosis (TB) screening tests (Tuberculin Skin Test-TST, Interferon Gamma Release Assay-IGRA: T-SPOT.TB) during biologic treatment in patients with rheumatic diseases and negative bas

Externí odkaz: https://doaj.org/article/abc10e7f84d9442f8bde157b6092e1af

Zobrazit plný text záznamu

Conversion and Reversion Rates of Tuberculosis Screening Assays in Patients With Rheumatic Diseases and Negative Baseline Screening Under Long-Term Biologic Treatment

Autor: Christos Koutsianas, Argyro Lazarini, Anastasia Makris, Dimitrios Vassilopoulos, Konstantinos Thomas, Katerina Antonatou, Christina Tsalapaki, Emilia Hadziyannis, Kalliopi Klavdianou, Chrisoula Hatzara

Publikováno v: Pathogens and Immunity
Pathogens and Immunity, Vol 5, Iss 1, Pp 34-51 (2020)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c67e0f023cd6ff175c2cd0ec8d4692af
https://pubmed.ncbi.nlm.nih.gov/32258853

Zobrazit plný text záznamu

AB0626 INCIDENCE OF SERIOUS INFECTIONS AND PATTERNS OF COTRIMOXAZOLE PROPHYLAXIS IN PATIENTSWITH ANCA-ASSOCIATED VASCULITIDES

Autor: Dimitrios Petras, Dimitrios Drekolias, Aglaia Chalkia, Katerina Antonatou, Kalliopi Klavdianou, Emilia Hadziyannis, Argyro Lazarini, Dimitrios Vassilopoulos, Konstantinos Thomas, Pinelopi Kouki, Anastasia Makris, Christina Tsalapaki, Chrisoula Hatzara

Publikováno v: Abstracts accepted for Publication.

Background: Infections are among the most serious complications in patients with aNCA-associated vasculitides (AAV) and contribute significantly in overall mortality. Objectives: To describe the incidence and risk factors for serious infections, as w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7fc0652b7f06310279914aa3aae2871b
https://doi.org/10.1136/annrheumdis-2019-eular.7243

Zobrazit plný text záznamu

AB0915 Frequent conversion and reverse conversion of tuberculin skin test but not of an interferon gamma release assay (T-SPOT.TB) during long term biologic treatment of rheumatic patients

Autor: Christina Tsalapaki, Katerina Antonatou, Dimitrios Vassilopoulos, Kalliopi Klavdianou, Argyro Lazarini, Chrisoula Hatzara, Anastasia Makris, Christos Koutsianas, Emilia Hadziyannis, Konstantinos Thomas

Publikováno v: Abstracts Accepted for Publication.

Background There are limited data regarding the value of tuberculosis (TB) rescreening in rheumatic patients on biologic (bDMARD) therapies who had a negative baseline TB screening. Objectives To examine the rates of conversion and reverse conversion

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6b9afd072c7c078873b21fc30605c238
https://doi.org/10.1136/annrheumdis-2017-eular.4582

Zobrazit plný text záznamu

Comparison of Two Gamma Interferon Release Assays and Tuberculin Skin Testing for Tuberculosis Screening in a Cohort of Patients with Rheumatic Diseases Starting Anti-Tumor Necrosis Factor Therapy

Autor: Dimitrios Vassilopoulos, Varvara Podia, Emilia Hadziyannis, Stamatoula Tsikrika, Anna Kandili, Nikolaos Stamoulis, Chrisoula Hatzara

Publikováno v: Clinical and Vaccine Immunology. 18:2102-2108

Gamma interferon release assays (IGRAs) are increasingly used for latentMycobacterium tuberculosisinfection (LTBI) screening in patients with rheumatic diseases starting anti-tumor necrosis factor (anti-TNF) therapies. We compared the performances of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45af95d85ba3c0df82cee6cd624722b0
https://doi.org/10.1128/cvi.05299-11

Zobrazit plný text záznamu

Frequent conversion of tuberculosis screening tests during anti-tumour necrosis factor therapy in patients with rheumatic diseases

Autor: Anastasia Makris, Anna Kandili, Georgios Georgiopoulos, Emilia Hadziyannis, Chrisoula Hatzara, Dimitrios Vassilopoulos, Christos Koutsianas

Publikováno v: Annals of the rheumatic diseases. 74(10)

To determine the rate of tuberculosis (TB) screening test conversion during anti-tumour necrosis factor (TNF) therapy in rheumatic patients with negative baseline screening.This was a prospective study of rheumatic patients with negative baseline TB

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc370811ec650b4e1fbde00aaa713743
https://pubmed.ncbi.nlm.nih.gov/24854354

Zobrazit plný text záznamu

AB0654 Drug Survival and Switching Rate of TNF Inhibitors in A Cohort of Patients with Ankylosing Spondylitis with Long Term Follow Up

Autor: Christina Tsalapaki, Argyro Lazarini, Chrisoula Hatzara, Konstantinos Thomas, Kalliopi Klavdianou, Christos Koutsianas, Dimitrios Vassilopoulos, Katerina Antonatou

Publikováno v: Annals of the Rheumatic Diseases. 75:1128.1-1128

Background Although the efficacy of TNF inhibitors (TNFi) in ankylosing spondylitis (AS) is well established, their long term survival (>5 years), baseline prognostic factors for their discontinuation and switching rate have not been adequately studi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1369fbd56991bbdb8531f2077b7b6728
https://doi.org/10.1136/annrheumdis-2016-eular.4885

Zobrazit plný text záznamu

Long-term safety of rituximab in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection

Autor: Ioannnis Mitroulis, Chrisoula Hatzara, Anna Kandili, Emilia Hadziyannis, Dimitrios Vassilopoulos

Publikováno v: Annals of the rheumatic diseases. 72(2)

Patients with rheumatic diseases and chronic, or less frequently, resolved hepatitis B virus (HBV) infection, can develop viral reactivation during antitumor necrosis factor therapy.1–3 Treatment with chemotherapeutic regimens that includes rituxim

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b404954be12c8429842b4c9800d70056
https://pubmed.ncbi.nlm.nih.gov/22930597

Zobrazit plný text záznamu

FRI0160 Comparative Drug Survival of Different Non-Anti-TNF IV Biologics After Anti-TNF Failure in Rheumatoid Arthritis Patients

Autor: Christos Koutsianas, Anna Kandili, Katerina Antonatou, Konstantinos Thomas, Dimitrios Vassilopoulos, Chrisoula Hatzara, Christina Tsalapaki

Publikováno v: Annals of the Rheumatic Diseases. 74:481.1-481

Background There are limited data to guide the selection of the first non-anti-TNF biologic DMARD (bDMARDs) after anti-TNF failure in rheumatoid arthritis (RA) patients. Objectives To evaluate the drug survival of non-anti-TNF IV bDMARDs in RA patien

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a7e79c9b2406158a501bbf8074842afa
https://doi.org/10.1136/annrheumdis-2015-eular.5008

Zobrazit plný text záznamu

AB0364 Cardiovascular comorbidities are common among greek patients with rheumatoid arthritis: A cross-sectional study

Autor: C. Tsalapaki, E. Kyritsi, Dimitrios Vassilopoulos, Antonios Antoniadis, Chrisoula Hatzara, Anna Kandili

Publikováno v: Annals of the Rheumatic Diseases. 71:658.11-658

Background Rheumatoid arthritis (RA) is associated with increased morbidity and mortality due to cardiovascular diseases. This association may be due to clustering of traditional cardiovascular risk factors among RA patients and/or to the chronic inf

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d273caaaba23252ad2711ba4bb0f2d6e
https://doi.org/10.1136/annrheumdis-2012-eular.364

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání